Ronapreve 120mg Injection Combi Pack contains two monoclonal antibodies used together for the emergency treatment of mild to moderate COVID-19 in adults and children aged 12 years and above and over 40 kg in weight. It is most effective if taken after an early laboratory diagnosis (within 7 to 10 days). This monoclonal antibody cocktail received emergency use approval from the Central Drug Standard Control Organization (CDSCO) on May 3rd, 2021. Apart from India, it has been approved for use in the United States, Switzerland, Germany, Italy, France, and several other countries. Ronapreve 120mg Injection Combi Pack should be given either into a vein (intravenously) or below the skin (subcutaneously) by a trained healthcare professional, preferably in a hospital setup. This is because the use of monoclonal antibodies may cause some side effects that may need immediate medical attention, such as severe allergic reactions (anaphylaxis). Patients should be monitored during and at least 1 hour after the injection. The most common side effects of this monoclonal antibody therapy are injection site reactions, fever, flushing, shortness of breath, chest tightness, nausea, and vomiting. If you experience any of these side effects, let your doctor know immediately. Before receiving this medicine, let your doctor know if you have any pre-existing medical conditions. Let the doctor know about your other medications if any, as they may affect or get affected by this COVID-19 drug. This medicine may be given to pregnant or breastfeeding women after considering its benefits against the risk to the baby or the mother. Contact Us If you want to know about the medicine availability or need help to identify where you can get it administered, please fill in your details here and we will reach out to you.
WHO GMP Certified
Long Expiry (>8 Months)
Genuine Medicine
Pay On Delivery
Secure Payment
LegitScript Certified Online Pharmacy
Ronapreve 120mg Injection Combi Pack contains two monoclonal antibodies used together for the emergency treatment of mild to moderate COVID-19 in adults and children aged 12 years and above and over 40 kg in weight. It is most effective if taken after an early laboratory diagnosis (within 7 to 10 days). This monoclonal antibody cocktail received emergency use approval from the Central Drug Standard Control Organization (CDSCO) on May 3rd, 2021. Apart from India, it has been approved for use in the United States, Switzerland, Germany, Italy, France, and several other countries. Ronapreve 120mg Injection Combi Pack should be given either into a vein (intravenously) or below the skin (subcutaneously) by a trained healthcare professional, preferably in a hospital setup. This is because the use of monoclonal antibodies may cause some side effects that may need immediate medical attention, such as severe allergic reactions (anaphylaxis). Patients should be monitored during and at least 1 hour after the injection. The most common side effects of this monoclonal antibody therapy are injection site reactions, fever, flushing, shortness of breath, chest tightness, nausea, and vomiting. If you experience any of these side effects, let your doctor know immediately. Before receiving this medicine, let your doctor know if you have any pre-existing medical conditions. Let the doctor know about your other medications if any, as they may affect or get affected by this COVID-19 drug. This medicine may be given to pregnant or breastfeeding women after considering its benefits against the risk to the baby or the mother. Contact Us If you want to know about the medicine availability or need help to identify where you can get it administered, please fill in your details here and we will reach out to you.
Treatment of Mild to moderate Coronavirus disease (COVID-19)
In Treatment of Mild to moderate Coronavirus disease (COVID-19) Ronapreve 120mg Injection Combi Pack contains monoclonal antibodies that help manage mild to moderate COVID-19 symptoms in those individuals who are at a high risk of developing severe COVID-19 infection and do not need oxygen administration. This medicine may help you to recover from the infection if diagnosed early before hospitalization. If you think you have come in contact with an infected person, or feel any of the symptoms, consult your doctor immediately.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them. ['Fever, Flushing (sense of warmth in the face, ears, neck and trunk), Breathlessness, Chest tightness, Nausea, Vomiting']
Follow your doctor's guidance regarding the dose and duration of this medication. Check the label before use.
Ronapreve 120mg Injection Combi Pack is a combination of two human immunoglobulins G-1 (Ig G1), neutralizing monoclonal antibodies, that bind at different sites on the spike protein of SARS-Co
Alcohol
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Ronapreve 120mg Injection Combi Pack . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Pregnancy
Seek medical advice from your doctor: Information regarding the use of Ronapreve 120mg Injection Combi Pack during pregnancy is not available. Doctor consultation is advised.
Breast feeding
Seek medical advice from your doctor: Information regarding the use of Ronapreve 120mg Injection Combi Pack during breastfeeding is not available. Doctor consultation is advised.
Driving
SAFE - Ronapreve 120mg Injection Combi Pack does not usually affect your ability to drive.
Kidney
Safe when prescribed by an expert: Ronapreve 120mg Injection Combi Pack is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Ronapreve 120mg Injection Combi Pack may not be needed in these patients. Doctor consultation is advised.
Liver
Seek medical advice from your doctor: There is limited information available on the use of Ronapreve 120mg Injection Combi Pack in patients with liver disease. Doctor consultation is advised.
If a dose of Ronapreve 120mg Injection Combi Pack is missed, it's advisable to consult your doctor.
Store in a refrigerator (2 - 8�C). Do not freeze.
Ronapreve 120mg Injection Combi Pack, a monoclonal antibody cocktail therapy, is used to treat mild to moderate symptoms of COVID-19 in non-hospitalized adults and adolescents aged 12 years and older, who weigh at least 40 kg. The use of monoclonal antibodies is not indicated in severe hospitalized cases of COVID-19 or in those who require oxygen therapy. Even after the treatment, you should continue to practice (COVID)-appropriate behavior such as wearing a mask, social distancing, avoiding sharing personal items, and frequent handwashing. Before taking this antibody cocktail therapy, inform your doctor if you have any underlying medical conditions like diabetes, heart disease, high blood pressure, kidney disease, asthma, etc. Patients should be monitored during treatment and at least one hour after the completion of the infusion. Severe allergic reactions might happen during and after the use of monoclonal antibodies. Inform your doctor or nurse immediately if you experience shortness of breath, rapid or slow heart rate, chest pain, swelling of the face or lips, sweating.
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
PlatinumRx is committed to providing reliable and accurate information to support informed customer decisions. However, all information made available on the Platform, including product descriptions, comparisons, and other content, is provided solely for general informational purposes. Such information is not intended to diagnose, prevent, treat, or cure any medical condition, nor should it be relied upon as a substitute for professional medical advice, diagnosis, or treatment.

More Medicines By Manufacturer
More Medicines With Salt
Top Selling Medicines
Top Selling Devices